Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

Broking agencies offer freebies to pull retail investors
Brokers have discovered a golden opportunity in the positive market sentiment to add investor accounts, even if it means offering these services for free.

Eros International plans IPO for Indian unit
AIM-listed integrated studio operator Eros International plc is planning to list its wholly-owned Indian subsidiary on the Bombay Stock Exchange in the current financial year.

News of the day

V V: JM Coetzee - The story of himself
All fiction has its autobiographical roots, but Evelyn Waugh puts it as “experience totally transformed”. The autobiographical impulse is particularly strong in JM Coetzee, the South African Nobel Prize winner (2003), but his writings lie at the frontier between life and the freedoms of fiction. Summertime (Harvill Secker, special Indian price Rs 799), the final volume of a trilogy — the other two being Boyhood and Youth — is subtitled Scenes from a Provincial Life, charts the border territory with multiple skills of a biographer and fiction writer so that it can pretty well mean what you would want it to be.
Online Business

Madras HC halts Daiichi's open offer for Zenotech

Zenotech Laboratories today said the Madras High Court has ordered Japanese drug firm Daiichi Sankyo not to go ahead with the planned open offer for an additional 20 per cent stake in the pharma firm. - Bajaj Auto to move SC on TVS issue - HC allows TVS to use Bajaj"s patented tech - MRF strike issues reaches Madras HC - Subhiksha gets interim stay on liquidator - Hearing on merger petition posted for Mar 27: Subhiksha - UK promoters make delisting offer for Avery India "By its order, the Hon"ble Madras High Court (Madurai Bench) has granted an interim injunction in connection with the offer (for an additional 20 per cent)," following complaints received from its minority stakeholders, Zenotech said in a filing to the Bombay Stock Exchange. Earlier in February, Daiichi Sankyo had announced it would launch an open offer for Zenotech to acquire 68.85 lakh shares or a 20 per cent stake. Daiichi had said it would pay up to Rs 78.23 crore, at Rs 113.62 a share, to Zenotech shareholders for the stake in the open offer, which was scheduled to begin on July 15 and close on August 3. However, the offer ran into controversy as the pharma firm complained to SEBI against Daiichi for allegedly not honouring a commitment to make the offer at Rs 160 per share. "In view of the receipt of the order before July 15, 2009, the shareholders of the Target Company (Zenotech) are requested to note that the Offer will not open as on July 15, 2009," the filing added. The shareholders are hereby advised not to tender any shares held by them and no shares will be accepted until an announcement is made in respect of the revised schedule of activities for the offer, the filing added. Ranbaxy picked up a 38 per cent stake in Zenotech, an affiliate of Ranbaxy, taking its shareholding in the Hyderabad-based firm to 45 per cent. Post the share purchase agreement between Daiichi and Ranbaxy in June 2008, it was mandatory for the Japanese firm to make an open offer to Zenotech. Shares of Zenotech were trading at Rs 107.10, up 1.61 per cent on the BSE today.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009